Sucampo Pharmaceuticals, Inc. (SCMP) Misses Q1 EPS by 2c

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) reported Q1 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $24.19 million.

For earnings history and earnings-related data on Sucampo Pharmaceuticals, Inc. (SCMP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c